The TGF-β co-receptor endoglin modulates the expression and transforming potential of H-Ras

Fonsatti, 2003, Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels, Oncogene, 22, 6557, 10.1038/sj.onc.1206813

Bernabeu, 2007, Novel biochemical pathways of endoglin in vascular cell physiology, J. Cell. Biochem., 102, 1375, 10.1002/jcb.21594

Bernabeu, 2009, The emerging role of TGF-β superfamily coreceptors in cancer, Biochim. Biophys. Acta, 1792, 954, 10.1016/j.bbadis.2009.07.003

Liu, 2002, Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion, Oncogene, 21, 8272, 10.1038/sj.onc.1206117

Craft, 2007, Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway, Oncogene, 26, 7240, 10.1038/sj.onc.1210533

Pérez-Gómez, 2007, A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis, Cancer Res., 67, 10268, 10.1158/0008-5472.CAN-07-1348

Quintanilla, 1986, Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis, Nature, 322, 78, 10.1038/322078a0

Buchmann, 1991, Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7, Cancer Res., 51, 4097

Rodriguez-Puebla, 1999, Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin, Mol. Carcinog., 26, 150, 10.1002/(SICI)1098-2744(199911)26:3<150::AID-MC3>3.0.CO;2-P

Caulin, 1995, Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype, Cell Growth Differ., 6, 1027

Cui, 1996, TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice, Cell, 86, 531, 10.1016/S0092-8674(00)80127-0

Lebrin, 2004, Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction, EMBO J., 23, 4018, 10.1038/sj.emboj.7600386

Quintanilla, 2003, Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis, Oncogene, 22, 5976, 10.1038/sj.onc.1206841

Pérez-Gómez, 2005, Characterization of murine S-endoglin isoform and its effects on tumor development, Oncogene, 24, 4450, 10.1038/sj.onc.1208644

Quintanilla, 1991, Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo, Carcinogenesis, 12, 1875, 10.1093/carcin/12.10.1875

Burns, 1991, Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice, Oncogene, 6, 2363

Conley, 2004, Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain, J. Biol. Chem., 279, 27440, 10.1074/jbc.M312561200

Guerrero-Esteo, 2002, Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II, J. Biol. Chem., 277, 29197, 10.1074/jbc.M111991200

Feig, 1988, Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins, Mol. Cell. Biol., 8, 2472, 10.1128/MCB.8.6.2472

Labbe, 1998, Smad2 and Smad3 positively and negatively regulate TGF-beta-dependent transcription through the forkhead DNA-binding protein FAST2, Mol. Cell, 2, 109, 10.1016/S1097-2765(00)80119-7

Conley, 2004, Endoglin controls cell migration and composition of focal adhesions, J. Biol. Chem., 279, 27440, 10.1074/jbc.M312561200

Mikheev, 2000, CArG binding factor A (CBF-A) is involved in transcriptional regulation of the rat Ha-ras promoter, Nucleic Acids Res., 28, 3762, 10.1093/nar/28.19.3762

Hu, 1995, Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase, Science, 268, 100, 10.1126/science.7701328

Dennler, 1998, Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene, EMBO J., 17, 3091, 10.1093/emboj/17.11.3091

Santibanez, 2007, Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling, J. Cell. Physiol., 210, 456, 10.1002/jcp.20878

Iglesias, 2000, Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas, Oncogene, 19, 4134, 10.1038/sj.onc.1203764

Bellon, 1993, Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions, Eur. J. Immunol., 23, 2340, 10.1002/eji.1830230943

Sukumar, 1988, Independent molecular pathways in initiation and loss of hormone responsiveness of breast carcinomas, Science, 240, 524, 10.1126/science.3282307

Oft, 2002, Metastasis is driven by sequential elevation of H-ras and Smad2 levels, Nat. Cell. Biol., 4, 487, 10.1038/ncb807

Derynck, 2003, Smad-dependent and Smad-independent pathways in TGF-beta family signalling, Nature, 6958, 577, 10.1038/nature02006

Bremner, 1990, Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7, Cell, 61, 407, 10.1016/0092-8674(90)90523-H

Zoumpourlis, 2003, Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis, Carcinogenesis, 24, 1159, 10.1093/carcin/bgg067

Der, 1986, Biological and biochemical properties of human ras H genes mutated at codon 61, Cell, 44, 167, 10.1016/0092-8674(86)90495-2

Frontelo, 1998, Transforming growth factor beta 1 induces squamous carcinoma cell variants with increased metastatic abilities and a disorganized cytoskeleton, Exp. Cell Res., 244, 420, 10.1006/excr.1998.4219

Santibanez, 1999, Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes, J. Cell. Biochem., 74, 61, 10.1002/(SICI)1097-4644(19990701)74:1<61::AID-JCB7>3.0.CO;2-B

Xie, 2004, Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro, Neoplasia, 6, 603, 10.1593/neo.04241

Yue, 2000, Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a smad-dependent pathway, J. Biol. Chem., 275, 30765, 10.1074/jbc.M000039200

Fink, 2003, TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines, Oncogene, 22, 1317, 10.1038/sj.onc.1206128

Santibanez, 2000, Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-beta(1) in transformed keratinocytes, Biochem. Biophys. Res. Commun., 273, 521, 10.1006/bbrc.2000.2946

Santibanez, 2002, Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes, Biochem. Biophys. Res. Commun., 296, 267, 10.1016/S0006-291X(02)00864-1

Wasylyk, 1998, Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signalling pathway, Trends Biochem. Sci., 23, 213, 10.1016/S0968-0004(98)01211-0

Yordy, 2000, Signal transduction and the Ets family of transcription factors, Oncogene, 19, 6503, 10.1038/sj.onc.1204036

Lu, 1994, Start site selection by Sp1 in the TATA-less human Ha-ras promoter, J. Biol. Chem., 269, 5391, 10.1016/S0021-9258(17)37700-1

Kwak, 2006, Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells, Mol. Cancer Res., 4, 209, 10.1158/1541-7786.MCR-05-0140

Hartsough, 1995, Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells, J. Biol. Chem., 270, 7117, 10.1074/jbc.270.13.7117

Hartsough, 1996, Altered transforming growth factor signaling in epithelial cells when ras activation is blocked, J. Biol. Chem., 271, 22368, 10.1074/jbc.271.37.22368

Blanco, 2005, Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex, J. Cell. Physiol., 204, 574, 10.1002/jcp.20311

Guo, 2004, CD105 inhibits transforming growth factor-beta-Smad3 signalling, Anticancer Res., 24, 1337

Rodríguez-Barbero, 2006, Endoglin modulation of TGF-beta1-induced collagen synthesis is dependent on ERK1/2 MAPK activation, Cell. Physiol. Biochem., 18, 135, 10.1159/000095181

Lee, 2007, The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells, J. Biol. Chem., 282, 21507, 10.1074/jbc.M700176200

Kretzschmar, 1999, A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras, Genes Dev., 13, 804, 10.1101/gad.13.7.804

Funaba, 2002, Modulation of Smad2-nediated signalling by extracellular signal-regulated kinase, J. Biol. Chem., 277, 41361, 10.1074/jbc.M204597200

Arany, 2008, Smad3 deficiency inhibits v-ras-induced transformation by suppression of JNK MAPK signaling and increased farnesyl transferase inhibition, Oncogene, 27, 2507, 10.1038/sj.onc.1210889

Owens, 2007, Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases, Oncogene, 26, 3203, 10.1038/sj.onc.1210412

Lastres, 1994, Phosphorylation of the human-transforming-growth-factor-beta-binding protein endoglin, Biochem. J., 301, 765, 10.1042/bj3010765

Koleva, 2006, Endoglin structure and function: determinants of endoglin phosphorylation by transforming growth factor-beta receptors, J. Biol. Chem., 281, 25110, 10.1074/jbc.M601288200

Zuo, 2009, Specific activation of mitogen-activated protein kinase by transforming growth factor-β receptors in lipid rafts is required for epithelial cell plasticity, Mol. Biol. Cell., 20, 1020, 10.1091/mbc.E08-09-0898

Kemp, 2005, Multistep skin cancer in mice as a model to study the evolution of cancer cells, Semin. Cancer Biol., 15, 460, 10.1016/j.semcancer.2005.06.003